H
HilleVax D
D
HLVX
1.83000
USD
-0.04
(-2.14%)
مغلق
حجم التداول
1,353
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
91,145,108
المقالات
العنوان: HilleVax
القطاع: Healthcare
الصناعة: Biotechnology
HilleVax Inc is a clinical-stage biopharmaceutical company. The company is focused on developing and commercializing novel vaccines. The firm's initial program, HIL-214, is a virus-like particle (VLP) based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis (AGE) caused by norovirus infection.